Skip to Content
Merck

Key Documents

View All Documentation

19-0490

Magnesium sulfate heptahydrate

SAJ first grade, ≥99.0%

Synonym(s):

Epsom salts

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
MgSO4 · 7H2O
CAS Number:
10034-99-8
Molecular Weight:
246.47
UNSPSC Code:
12352302
PubChem Substance ID:
329751793
EC Number:
231-298-2
MDL number:
MFCD00149785
Assay:
≥99.0%
Grade:
SAJ first grade
Form:
fine crystals
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

SAJ first grade

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

assay

≥99.0%

form

fine crystals

availability

available only in Japan

pH

5.0-8.0 (50 g/L)

SMILES string

O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O

InChI

1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

WRUGWIBCXHJTDG-UHFFFAOYSA-L

Still not finding the right product?

Explore all of our products under Magnesium sulfate heptahydrate

Storage Class

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

19-0490-8-25KG-J: + 19-0490-5-500G-J:

jan

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
U0247
U6250
U6156
U5145
U4127

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
A P Morrison et al.
British journal of anaesthesia, 110(5), 702-712 (2013-03-28)
Spinal anaesthesia is the primary anaesthetic technique for many types of surgery. Adjuncts to the local anaesthetics (LA) used in spinal anaesthesia can exhibit undesirable side-effects, limiting their use, but magnesium may have advantages in this respect. We sought randomized
Karen J Gibbins et al.
Obstetrics and gynecology, 121(2 Pt 1), 235-240 (2013-01-25)
Clinical trials support the efficacy and safety of magnesium sulfate for cerebral palsy prevention. We evaluated the implementation of a clinical protocol for the use of magnesium for cerebral palsy prevention in our large women's hospital, focusing on uptake, indications
View All Related Papers